(FM) Unidad de Medicina Traslacional
Departamento académico
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Barcelona, EspañaPublicacions en col·laboració amb investigadors/es de Institut d'Investigacions Biomèdiques August Pi i Sunyer (9)
2024
-
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia
Nature Communications, Vol. 15, Núm. 1
2023
-
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
Nature Communications, Vol. 14, Núm. 1
-
Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma
Journal for immunotherapy of cancer, Vol. 11, Núm. 2
2022
-
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial
Cancers, Vol. 14, Núm. 20
2021
-
Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma
Leukemia, Vol. 35, Núm. 5, pp. 1438-1450
2020
-
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma
Blood, Vol. 136, Núm. 2, pp. 199-209
2014
-
Heterogeneous micromechanical properties of the extracellular matrix in healthy and infarcted hearts
Acta Biomaterialia, Vol. 10, Núm. 7, pp. 3235-3242
2009
-
Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia
European Journal of Cancer, Vol. 45, Núm. 10, pp. 1877-1889
2003
-
Imatinib mesylate (STI571) treatment in patients with chronic-phase chronic myelogenous leukaemia previously submitted to autologous stem cell transplantation
British Journal of Haematology, Vol. 120, Núm. 3, pp. 500-504